The Innovative Genomics Institute (IGI) is undertaking an exciting new project with global biopharmaceutical company AstraZeneca, focused on identifying potential drug targets in DNA Damage Response (DDR), a pathway at the core of many cancers. As the connection between complex DDR mechanisms and various forms of cancer is being increasingly understood, researchers at the IGI […]

This series introduces the public and fellow researchers to our talented scientists. We interview different IGI members to find out who they are and what makes them passionate about science. — — Dr. Shaheen Kabir became an IGI-AstraZeneca Postdoctoral Fellow in July 2015 and works in Luke Gilbert’s at UCSF. She studies cancer cells that are resistant […]

IGI investigator Luke Gilbert, an assistant professor at UCSF, has received a New Innovator Award from the National Institutes of Health (NIH). The grant provides $1.5 million over five years and is awarded to exceptionally creative early career investigators who propose innovative, high-impact projects. Gilbert is one of 58 award recipients, pioneering bold approaches to address major challenges […]